血清神经元特异性烯醇化酶及S100B蛋白水平在早期评价窒息新生儿脑损伤中的意义(3)
第1页 |
参见附件。
[4]Herrmann M, Jost S, Kvti S, et al. Temporal profile of release of neurobiochemical markers of brain damage after traumatic brain injury is associated with intracranial pathology as demonstrated in cranial computerized to tomography [J]. Neurotrauma,2000,17(2):113-122.
[5]Nagdyman N, Grimmer I, Scholz T, et al. Predictive value of brain-specific proteins in serum for neurodevelopmental outcome after birth asphyxia [J]. Pediatr Res,2003,54(2):270-275.
[6]Bloomfield SM, Mckinnev J, Smith L, et al. Reliability of S100B in predicting severity of central nervous system injury [J]. Neurocrit Care,2007,6(6):121-138.
[7]Beger RP, Pierce Mc, Wisniewskis R, et al. Neuron-specific enolase and S100B in cerebrospinal fluid after severe traumatic brain injury in infants and children [J]. Pediateics,2002,109(2):31.
[8]Woertgen C, Potheorl RD. Serum S100B protein in severe head injury [J]. Neurosurgery,2000,46(4):1026-1027.
[9]王庆红,宋健辉,王霞,等.血清S100B蛋白在新生儿窒息后脑损伤中的临床意义[J].中国当代儿科杂志,2005,7(4):318-320.
[10]Murabavashi M, Minato M, Okuhata Y, et al. Kinetics of serum S100B in newborns with intracranial lesions [J]. Pediatr Int,2008,5(1):17-22.
[11]Bandyopadhyay S, Hennes H, Gorelick G, et al. Serum neuro-nspecific enolase as a predictor of short term outcome in children with closed traumatic brain injury [J]. Acad Emerq Med,2005,12(8):732-738.
[12]Gazzolo D, Abella R, Marinoni E, et al. Circulating biochemical markers of brain damage in infants complicated by ischemia repefusion injury [J]. Cardiovasc Hematol Agents Med Chem,2009,4(2):108-126.
(收稿日期:2009-07-30)
您现在查看是摘要介绍页,详见PDF附件。